These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 29800725

  • 1. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M, Dong J, Wang Y, Zhang J, Zhang M, Wu Z, Lv Y, Wu R.
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [Abstract] [Full Text] [Related]

  • 2. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W, Fang FF, Li B, Cheng BB, Ling CQ.
    Asian Pac J Cancer Prev; 2012 Aug; 13(9):4807-14. PubMed ID: 23167424
    [Abstract] [Full Text] [Related]

  • 3. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y, Zhang M, Zhang Z, Jia Y, Zhang C, Peng L.
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [Abstract] [Full Text] [Related]

  • 4. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [Abstract] [Full Text] [Related]

  • 5. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T, Wu X, Li Y, Lu W, Zheng F, Zhang C, Long Q, Qiu H, Li Y, Ge Q, Chen M, Yu X, Chen W, Zhang H, Huang W, Luo M, Deng W, Li L.
    Cell Physiol Biochem; 2018 Dec; 46(4):1365-1380. PubMed ID: 29689552
    [Abstract] [Full Text] [Related]

  • 6. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H, Dong Q, Luo X, Shi B, Wang H, Gao H, Kong J, Zhang J, Li Z.
    Cancer Lett; 2014 Jan 01; 342(1):113-20. PubMed ID: 24007863
    [Abstract] [Full Text] [Related]

  • 7. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.
    Liu X, Gao X, Yang Y, Yang D, Guo Q, Li L, Liu S, Cong W, Lu S, Hou L, Wang B, Li N.
    Apoptosis; 2024 Aug 01; 29(7-8):1161-1184. PubMed ID: 38743191
    [Abstract] [Full Text] [Related]

  • 8. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.
    Oncol Rep; 2014 Jan 01; 31(1):216-22. PubMed ID: 24173654
    [Abstract] [Full Text] [Related]

  • 9. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.
    Gao AM, Ke ZP, Wang JN, Yang JY, Chen SY, Chen H.
    Carcinogenesis; 2013 Aug 01; 34(8):1806-14. PubMed ID: 23563091
    [Abstract] [Full Text] [Related]

  • 10. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J, Nan K, Yao Y, Tian T.
    J Exp Clin Cancer Res; 2018 Mar 12; 37(1):52. PubMed ID: 29530052
    [Abstract] [Full Text] [Related]

  • 11. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
    Dong C, Zhao B, Long F, Liu Y, Liu Z, Li S, Yang X, Sun D, Wang H, Liu Q, Liang R, Li Y, Gao Z, Shao S, Miao QR, Wang L.
    Oncotarget; 2016 Feb 23; 7(8):8850-65. PubMed ID: 26840457
    [Abstract] [Full Text] [Related]

  • 12. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
    Zhang J, Luo N, Tian Y, Li J, Yang X, Yin H, Xiao C, Sheng J, Li Y, Tang B, Li R.
    Oncotarget; 2017 Apr 11; 8(15):24728-24740. PubMed ID: 28445968
    [Abstract] [Full Text] [Related]

  • 13. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F, Hou YQ, Song Y, Yuan ZJ.
    Anat Rec (Hoboken); 2013 Jan 11; 296(1):56-63. PubMed ID: 23125179
    [Abstract] [Full Text] [Related]

  • 14. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
    Hu Z, Lv G, Li Y, Li E, Li H, Zhou Q, Yang B, Cao W.
    J Exp Clin Cancer Res; 2016 Apr 22; 35():71. PubMed ID: 27102814
    [Abstract] [Full Text] [Related]

  • 16. Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.
    Liu D, Liu Y, Liu M, Ran L, Li Y.
    Future Oncol; 2013 Apr 22; 9(4):595-604. PubMed ID: 23560381
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods.
    Zhong X, Xiong M, Meng X, Gong R.
    J Exp Clin Cancer Res; 2010 Aug 20; 29(1):115. PubMed ID: 20727186
    [Abstract] [Full Text] [Related]

  • 18. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.
    Ling S, Li J, Shan Q, Dai H, Lu D, Wen X, Song P, Xie H, Zhou L, Liu J, Xu X, Zheng S.
    Mol Oncol; 2017 Jun 20; 11(6):682-695. PubMed ID: 28417539
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
    Wang H, Jiang H, Zhou M, Xu Z, Liu S, Shi B, Yao X, Yao M, Gu J, Li Z.
    Cancer Lett; 2009 Jun 28; 279(1):30-8. PubMed ID: 19217205
    [Abstract] [Full Text] [Related]

  • 20. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
    Zhang G, Zeng X, Zhang R, Liu J, Zhang W, Zhao Y, Zhang X, Wu Z, Tan Y, Wu Y, Du B.
    Phytomedicine; 2016 Nov 15; 23(12):1329-1336. PubMed ID: 27765352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.